Nodelman Oleg's Form 4 filing
Nuvation Bio Inc. (NUVB) · filed Sep 21, 2023
- Accession no.
- 0000935836-23-000619
- Filed
- Sep 21, 2023, 8:08 PM ET
- Trade date
- Feb 19-21, 2023
- Filing delay
- 214 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $6.69M. It was filed 214 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0000935836-23-000621 (Sep 22, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nodelman OlegCIK 0001454385 | Director |
| EcoR1 Capital Fund, L.P.CIK 0001567938 | Director |
| EcoR1 Capital, LLCCIK 0001587114 | Director |
| EcoR1 Capital Fund Qualified, L.P.CIK 0001598292 | Director |
| EcoR1 Venture Opportunity Fund, LPCIK 0001778011 | Director |
| Biotech Opportunity GP, LLCCIK 0001816370 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2023 | Class A Common Stock | PPurchaseAcquired | +5,143,000 | $1.26 | +$6,460,636.6 | 12,504,675 | Indirect | |
| Feb 20, 2023 | Class A Common Stock | PPurchaseAcquired | +117,100 | $1.36 | +$159,490.2 | 12,621,775 | Indirect | |
| Feb 21, 2023 | Class A Common Stock | PPurchaseAcquired | +53,000 | $1.36 | +$72,138.3 | 12,674,775 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.